Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Migueres (Strasbourg, France), C. Delmas (Saverne, France), J. Petit Thomas (Colmar, France), H. Kuntz (Strasbourg, France), E. Peri-Fontaa (Strasbourg, France), P. Schultz (Strasbourg, France), M. Velten (Strasbourg, France), F. De Blay (Strasbourg, France). Laryngeal dysfunction is predominant in asthmatic women treated by inhaled corticosteroids. 2217

Member's Comments

No comment yet.

Related content which might interest you: Reduction of inhaled corticosteroids in asthmatic children Source: Eur Respir J 2007; 30: Suppl. 51, 616s Year: 2007 Persistent airway inflammation in young allergic wheezing children treated with inhaled corticosteroids Source: Annual Congress 2003 - Current issues on wheezing in infancy Year: 2003 Adrenal function improvement of most asthmatic children on inhaled corticosteroids Source: Eur Respir J 2006; 28: Suppl. 50, 260s Year: 2006 Effect of add-on montelukast to inhaled corticosteroids on excessive airway narrowing in adult asthmatics Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009 Airway inflammation and inhaled corticosteroids in COPD Source: Eur Respir J, 49 (6) 1700289; 10.1183/13993003.00289-2017 Year: 2017 Risks of pneumonia in asthmatic patients taking inhaled corticosteroids Source: Annual Congress 2010 - Management of airway disease Year: 2010 Perception of the of inhaled corticosteroids role in treatment of bronchial asthma in Saudi adult patients Source: Eur Respir J 2004; 24: Suppl. 48, 285s Year: 2004 Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids Source: Eur Respir J 2017; 49(1): 1600839; DOI: 10.1183/13993003.00839-2016 Year: 2017 Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids Source: Eur Respir J, 49 (6) 1700848; 10.1183/13993003.00848-2017 Year: 2017 Efficacy of systemic corticosteroids in refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β2 agonist inhalation Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2010 Effects of inhaled corticosteroids on cough in asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 347s Year: 2004 Cough variant asthma treated with bronchodilators, without inhaled corticosteroids Source: Annual Congress 2009 - From cough to sound analysis of breathing Year: 2009 The importance of early applying inhaled corticosteroids in patients with mild bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 57s Year: 2002 Obesity and the response to inhaled budesonide in patients with asthma Source: Annual Congress 2007 - Asthma subphenotypes Year: 2007 Mycobiota of the pharynx in patients with persistent bronchial asthma who constantly applying the inhaled corticosteroids Source: Annual Congress 2012 - Asthma: assessment and treatment Year: 2012 Safety of inhaled corticosteroids reduction in asthmatic children Source: Eur Respir J 2006; 28: Suppl. 50, 712s Year: 2006 Effects of inhaled corticosteroids on asthmatic inflammation: The FeNOtype trial Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Reduction of respiratory resistance after fluticasone inhaled therapy in asthmatic preschool children Source: Eur Respir J 2004; 24: Suppl. 48, 166s Year: 2004 Low risk of adrenal dysfunction in children with severe asthma treated with high-dose inhaled glucocorticoids Source: Eur Respir J 2005; 26: Suppl. 49, 161s Year: 2005 Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids Source: Breathe 2010; 6: 365 Year: 2010